Parameters for the collection and management of biospecimens
Research consortium launches multisite investigations of the impact of aberrant immunity
Neurooncology team uses genetic mapping to target treatment
New reviews offer insights on immunotherapies
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Oral immunotherapy drug is first of its kind
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
Enroll patients now in KEYNOTE-630 trial
Analysis provides evidence to guide treatment of uncommon RCC subtypes
Immunotherapy, PARP inhibitors and a targeted therapy
Study includes largest cohort to date